NCT00314041View on ClinicalTrials.gov

Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants

PHASE2CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

June 30, 1997

Primary Completion Date

April 30, 1998

Study Completion Date

April 30, 1998

Conditions
Meningitis, Meningococcal
Interventions
BIOLOGICAL

Meningococcal C

BIOLOGICAL

DTP/Hib

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00314041 - Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants | Biotech Hunter | Biotech Hunter